Related Experiment Video
Updated: Jun 9, 2025

06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.7K
Drug development in higher-risk myelodysplastic syndromes
Sangeetha Venugopal1, Mikkael A Sekeres2
1Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. svenugopal@miami.edu.
Blood Cancer Journal
|October 25, 2024
Summary
No abstract available in PubMed .

